TipRanks
Advertisement
Advertisement

TNXP Stock Latest News

Tonix Pharmaceuticals price target lowered to $26 from $27 at Raymond James
The FlyTonix Pharmaceuticals price target lowered to $26 from $27 at Raymond James
2d ago
TNXP
Tonix Pharma Files Technical Regulatory Disclosure Update
PremiumCompany Announcements
Tonix Pharma Files Technical Regulatory Disclosure Update
7d ago
8K
TNXP
Tonix Pharma Faces Generic TONMYA Patent Challenge
PremiumCompany Announcements
Tonix Pharma Faces Generic TONMYA Patent Challenge
20d ago
8K
TNXP
Tonix Pharma expands TONMYA Medicare Part D coverage
PremiumCompany Announcements
Tonix Pharma expands TONMYA Medicare Part D coverage
1M ago
8K
TNXP
Tonix announces second major managed Medicare payer agreement for TONMYA
PremiumThe Fly
Tonix announces second major managed Medicare payer agreement for TONMYA
1M ago
TNXP
Tonix Pharmaceuticals promotes Thomas Englese to chief commercial officer
PremiumThe FlyTonix Pharmaceuticals promotes Thomas Englese to chief commercial officer
1M ago
TNXP
Tonix Pharma Appoints New Chief Commercial Officer
Premium
Company Announcements
Tonix Pharma Appoints New Chief Commercial Officer
1M ago
8K
TNXP
Dollar General, TeraWulf, Schwab, Tonix, Warner Bros Shock
Premium
Weekend Updates
Dollar General, TeraWulf, Schwab, Tonix, Warner Bros Shock
2M ago
DG
WBD
Tonix Pharma Rallies as Insider Bets and Pipeline Build
PremiumWeekend Updates
Tonix Pharma Rallies as Insider Bets and Pipeline Build
2M ago
TNXP
Charles Schwab, Tonix, Boston Scientific, Alcoa, Illumina
PremiumWeekend Updates
Charles Schwab, Tonix, Boston Scientific, Alcoa, Illumina
2M ago
AA
BSX
Tonix Pharma Names CEO Seth Lederman Interim CMO
PremiumCompany Announcements
Tonix Pharma Names CEO Seth Lederman Interim CMO
2M ago
8K
TNXP
Tonix Pharmaceuticals: Stronger-Than-Expected Tonmya Launch, Expanded Market Access, and Advancing Pipeline Underpin Buy Rating
PremiumRatings
Tonix Pharmaceuticals: Stronger-Than-Expected Tonmya Launch, Expanded Market Access, and Advancing Pipeline Underpin Buy Rating
2M ago
TNXP
Tonix Pharmaceuticals Earnings Call Highlights Surging TONMYA Momentum
PremiumCompany AnnouncementsTonix Pharmaceuticals Earnings Call Highlights Surging TONMYA Momentum
2M ago
TNXP
Tonix Pharmaceuticals price target raised to $27 from $25 at Raymond James
Premium
The Fly
Tonix Pharmaceuticals price target raised to $27 from $25 at Raymond James
2M ago
TNXP
Tonix Pharmaceuticals reports Q2 EPS ($2.44), consensus ($2.62)
Premium
The Fly
Tonix Pharmaceuticals reports Q2 EPS ($2.44), consensus ($2.62)
2M ago
TNXP
Options Volatility and Implied Earnings Moves This Week, August 10 – August 13, 2026
PremiumMarket News
Options Volatility and Implied Earnings Moves This Week, August 10 – August 13, 2026
2M ago
B
JD
TNXP Earnings this Week: How Will it Perform?
PremiumPre-Earnings
TNXP Earnings this Week: How Will it Perform?
3M ago
TNXP
Tonix Pharmaceuticals receives Type C meeting minutes from FDA for TNX-4800
PremiumThe Fly
Tonix Pharmaceuticals receives Type C meeting minutes from FDA for TNX-4800
3M ago
TNXP
Tonix Pharma Advances Phase 2 Lyme Disease Vaccine Study
PremiumCompany Announcements
Tonix Pharma Advances Phase 2 Lyme Disease Vaccine Study
3M ago
8K
TNXP
Tonix Pharma announces upcoming retirement of chief medical officer
PremiumCompany AnnouncementsTonix Pharma announces upcoming retirement of chief medical officer
3M ago
8K
TNXP
Tonix Pharma expands Medicare coverage for TONMYA therapy
Premium
Company Announcements
Tonix Pharma expands Medicare coverage for TONMYA therapy
3M ago
8K
TNXP
Tonix Pharmaceuticals announces managed Medicare agreement for Tonmya
Premium
The Fly
Tonix Pharmaceuticals announces managed Medicare agreement for Tonmya
3M ago
TNXP

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >